News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
227,024 Results
Type
Article (5034)
Company Profile (18)
Press Release (221972)
Multimedia
Podcasts (1)
Webinars (4)
Section
Business (82216)
Career Advice (461)
Deals (15047)
Drug Delivery (8)
Drug Development (19065)
Employer Resources (30)
FDA (3676)
Job Trends (3904)
News (120127)
Policy (7506)
Tag
Academia (293)
Accelerated approval (2)
Adcomms (3)
Allergies (10)
Alliances (14807)
ALS (25)
Alzheimer's disease (253)
Antibody-drug conjugate (ADC) (12)
Approvals (3700)
Artificial intelligence (50)
Autoimmune disease (5)
Automation (4)
Bankruptcy (97)
Best Places to Work (2863)
Biosimilars (17)
Biotechnology (21)
Bladder cancer (13)
Brain cancer (7)
Breast cancer (54)
Cancer (537)
Cardiovascular disease (29)
Career advice (393)
Career pathing (3)
CAR-T (42)
CDC (2)
Cell therapy (119)
Cervical cancer (2)
Clinical research (16164)
Collaboration (214)
Compensation (212)
Complete response letters (2)
COVID-19 (302)
CRISPR (12)
C-suite (138)
Cystic fibrosis (17)
Data (657)
Denatured (1)
Depression (10)
Diabetes (52)
Diagnostics (2053)
Digital health (4)
Diversity, equity & inclusion (13)
Drug discovery (16)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (15)
Earnings (41351)
Editorial (2)
Employer branding (6)
Employer resources (32)
Events (38166)
Executive appointments (365)
FDA (4047)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (225)
Gene editing (20)
Generative AI (2)
Gene therapy (58)
GLP-1 (121)
Government (415)
Guidances (93)
Healthcare (5043)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (18)
Indications (9)
Infectious disease (318)
Inflammatory bowel disease (26)
Inflation Reduction Act (3)
Influenza (3)
Intellectual property (18)
Interviews (53)
IPO (7863)
IRA (3)
Job creations (1122)
Job search strategy (360)
Kidney cancer (9)
Labor market (5)
Layoffs (101)
Leadership (5)
Legal (2335)
Liver cancer (19)
Lung cancer (62)
Lymphoma (38)
Management (10)
Manufacturing (65)
MASH (31)
Medical device (3875)
Medtech (3876)
Mergers & acquisitions (7464)
Metabolic disorders (145)
Multiple sclerosis (9)
NASH (6)
Neurodegenerative disease (14)
Neuropsychiatric disorders (1)
Neuroscience (377)
NextGen: Class of 2025 (1675)
Non-profit (730)
Now hiring (4)
Obesity (63)
Opinion (30)
Ovarian cancer (19)
Pain (15)
Pancreatic cancer (17)
Parkinson's disease (36)
Partnered (4)
Patents (28)
Patient recruitment (37)
Peanut (5)
People (24750)
Pharmaceutical (5)
Pharmacy benefit managers (2)
Phase I (4830)
Phase II (7022)
Phase III (5589)
Pipeline (772)
Policy (11)
Postmarket research (625)
Preclinical (1894)
Press Release (66)
Prostate cancer (37)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (88)
Real estate (1877)
Recruiting (8)
Regulatory (5177)
Reports (17)
Research institute (302)
Resumes & cover letters (68)
Rett syndrome (8)
Schizophrenia (24)
Series A (36)
Series B (26)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1013)
Stomach cancer (1)
Supply chain (12)
Tariffs (5)
Vaccines (44)
Venture capital (3)
Weight loss (23)
Women's health (2)
Date
Today (18)
Last 7 days (134)
Last 30 days (564)
Last 365 days (9355)
2025 (4815)
2024 (11029)
2023 (13197)
2022 (18662)
2021 (19678)
2020 (18240)
2019 (13205)
2018 (10207)
2017 (10003)
2016 (9162)
2015 (12119)
2014 (9588)
2013 (7708)
2012 (8330)
2011 (8796)
2010 (8635)
Location
Africa (185)
Alabama (15)
Alaska (2)
Arizona (63)
Arkansas (1)
Asia (11531)
Australia (1626)
California (2353)
Canada (824)
China (90)
Colorado (98)
Connecticut (103)
Delaware (41)
Europe (24768)
Florida (357)
Georgia (41)
Idaho (24)
Illinois (124)
India (7)
Indiana (74)
Iowa (7)
Japan (100)
Kansas (24)
Kentucky (13)
Louisiana (6)
Maine (43)
Maryland (258)
Massachusetts (1896)
Michigan (89)
Minnesota (154)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (29)
New Hampshire (16)
New Jersey (695)
New Mexico (5)
New York (561)
North Carolina (363)
North Dakota (4)
Northern California (1136)
Ohio (70)
Oklahoma (5)
Oregon (4)
Pennsylvania (405)
Puerto Rico (1)
Rhode Island (14)
South America (276)
South Carolina (10)
Southern California (842)
Tennessee (48)
Texas (289)
United States (8448)
Utah (70)
Virginia (60)
Washington D.C. (15)
Washington State (201)
West Virginia (2)
Wisconsin (27)
227,024 Results for "omeros corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Omeros Corporation Reports First Quarter 2025 Financial Results
May 15, 2025
·
14 min read
Press Releases
Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025
May 12, 2025
·
2 min read
Press Releases
Omeros Announces Webcast Details for Annual Meeting of Shareholders
June 24, 2025
·
2 min read
Press Releases
Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
May 12, 2025
·
6 min read
Press Releases
Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program
April 10, 2025
·
9 min read
Press Releases
Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results
March 31, 2025
·
20 min read
Press Releases
Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA
June 27, 2025
·
7 min read
Press Releases
Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025
March 26, 2025
·
2 min read
Press Releases
Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program
March 24, 2025
·
8 min read
Business
Omeros Corporation Reports First Quarter 2024 Financial Results
Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the first quarter ended March 31, 2024.
May 15, 2024
·
18 min read
1 of 22,703
Next
